Efficacy of Neoadjuvant Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma

References

• Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118–23.
   PubMed Web of Science ®Google Scholar
• Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845–57.
   Google Scholar
• Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol 1998; 9: 951–62.
   PubMed Web of Science ®Google Scholar
• Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300–13.
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by trans-hiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993; 11: 1118–23.
   Google Scholar
• Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156–63.
   Google Scholar
• Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally ad-vanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829–37.
   PubMed Web of Science ®Google Scholar
• Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997; 80: 1011–20.
   PubMed Web of Science ®Google Scholar
• Stockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 2001; 40: 566–73.
   PubMed Web of Science ®Google Scholar
• Nygaard K, Hagen S, Hansen HS, et al. Preoperative radio-therapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of peroperative radiotherapy and chemotherapy. The second Scandinavian trial in esopha-geal cancer. J Surg 1992; 16: 1104–9.
   Google Scholar
• Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337: 161–7.
   PubMed Web of Science ®Google Scholar
• Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779–84.
   PubMed Web of Science ®Google Scholar
• Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarci-noma. N Engl J Med 1996; 335: 462–7.
   PubMed Web of Science ®Google Scholar
• Urba SG, Orringer MB, Turrisi A, et al. A randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal cancer. J Clin Oncol 2000; 19: 303–13.
   Web of Science ®Google Scholar
• Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long-term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165–74.
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer: AJCC cancer staging manual 5th ed. Philadelphia, PA: Lippincott-Raven; 1997. p. 65–9.
   Google Scholar
• Tio TL, Cohen P, Coene PP, et al. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new 1987 TNM system. Gastro-enterology 1989; 96: 1478–86.
   Google Scholar
• Burmeister BH, Smithers BM, Fitzgerald L, et al. A rando-mized phase III trial of peroperative chemoradiation followed by surgery versus surgery alone for localized resectable cancer of the esophagus. Proc Am Soc Clin Oncol 2002; Abstr 518.
   Google Scholar
• Heath El, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000; 18: 868–76.
   PubMed Web of Science ®Google Scholar
• Carey RW, Hilgenberg AD, Wilkins EW Jr, et al. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 1993; 11: 99–105.
   PubMed Web of Science ®Google Scholar
• Hoff SJ, Stewart JR, Sawyers JL, et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993; 56: 282–6.
   PubMed Web of Science ®Google Scholar
• Powell ME, Hoskin PJ, Saunders MI, Foy CJ, Dische S. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys 1997; 38: 133–6.
   PubMedGoogle Scholar
• Jeremic B, Shibamoto Y, Acimovic L, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluor-ouraciUcisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40: 1061–6.
   PubMed Web of Science ®Google Scholar
• Wright CD, Wain JC, Lynch TJ, et al. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radio-therapy: a phase I and II study. J Thorac Cardiovasc Surg 1997; 114: 811–5.
   PubMed Web of Science ®Google Scholar
• Raoul JL, Le Prise E, Meunier B, Heresbach D, Campion JP, Launois B. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998; 42: 29–34.
   PubMed Web of Science ®Google Scholar
• Naunheim KS, Petruska PJ, Roy TS, Schlueter JM, Kim H, Baue AE. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995; 59: 1085–90.
   PubMed Web of Science ®Google Scholar
• Jones DR, Parker LA Jr, Detterbeck FC, Egan TM. Inade-quacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy Cancer 1999; 85: 1026–32.
   Google Scholar
• Mallery S, DeCamp M, Bueno R, et al. Pretreatment staging by endoscopic ultrasonography does not predict complete re-sponse to neoadjuvant chemoradiation in patients with eso-phageal carcinoma. Cancer 1999; 86: 764–9.
   PubMed Web of Science ®Google Scholar
• Beseth BD, Bedford R, IsacoffWH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiother-apy. Am Surg 2000; 66: 827–31.
   Google Scholar
• Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233: 300–9.
   PubMed Web of Science ®Google Scholar
• Reed CE. Surgical management of esophageal carcinoma. Oncologist 1999; 4: 95–105.
   PubMedGoogle Scholar
• Ferguson MK, Reeder LB, Hoffman PC, Haraf DJ, Drinkard LC, Vokes EE. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1995; 2: 101–6.
   PubMed Web of Science ®Google Scholar
• Bidoli P, Bajetta E, Stani SC, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 2002; 94: 352–61.
   PubMed Web of Science ®Google Scholar
• Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001; 49: 657–64.
   PubMed Web of Science ®Google Scholar
• Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20: 29–36.
   Google Scholar
• Herskovic A, Martz K, al-Sarraf M, et al. Combined che-motherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8.
   Google Scholar
• Minsky BD, Pajak TF, Ginsberg RJ, et al. TNT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167–74.
   PubMed Web of Science ®Google Scholar
• Bedenne L, Michel P, Bouche O, et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Chin Oncol 2002; Abstr 519.
   Google Scholar
• Adelstein DJ, Rice TW, Rybicki LA, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluor-ouracil-based therapy. J Chin Oncol 2000; 18: 2032–9.
   PubMed Web of Science ®Google Scholar
• Urba S, Orringer M, Lannettoni M, et al. A phase II trial of preoperative cisplatin, paclitaxel, and radiation therapy before trans-hiatal esophagectomy in patients with locoregional eso-phageal cancer. Proc Am Soc Chin Oncol 2000; Abstr 960.
   Google Scholar
• de Lange SM, van Groeningen CJ, Kroep JR, et al. Neoadju-vant cisplatin-gemcitabine plus GM-CSF in locally advanced esophageal cancer (LAEC): a phase II study. Proc Am Soc Chin Oncol 2002; Abstr 2396.
   Google Scholar
• Keresztes R, Port J, Ferrara CA, Altorki NK. Taxol and carboplatin, an effective preoperative regimen for carcinoma of the esophagus: results of a phase II trial. Proc Am Soc Chin Oncol 2002; Aabstr 636.
   Google Scholar